Multiple cancers can be treated with tyrosine kinase inhibitors, which block proteins that aid cancer growth.
In most cases, MEK inhibitors are combined with BRAF inhibitors, such as Dabrafenib, Encorafenib, and Vemurafenib-Block B-Raf, to deal cell growth.
It targets the KRAS G12C and is the first approved treatment for any KRAS mutation in NSCLC.
Monoclonal antibodies, produced in the laboratory and resembling immune system defenses, treat various abnormal cell types.
The immune response medication forms convey chemotherapy to the growths and treat abnormal cells like those of the bosom and lymphoma.
With mixes like Amalaki, Rasayana Ayurveda detoxifies, boosts immunity, and balances the body's energy; this may deal cancer mutations.